Related Experiment Video
Updated: Jun 1, 2026

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
Mitochondrial RNA degradation regulates differentiation, stemness, and immune sensitivity in acute myeloid leukemia
Geethu Emily Thomas1, Veronique Voisin1, Kazem Nouri1,2
1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Abstract:
Eukaryotic cells have separate genomes in the nucleus and mitochondria. Mitochondrial DNA is transcribed bi-directionally to generate mitochondrial RNA (mtRNA) and dsRNA as a by-product of this transcription. We demonstrate that mtRNA transcription and degradation are increased in AML (Acute Myeloid Leukemia) cells and stem cells resulting in higher rates of mtRNA turnover. We discover that the mitochondrial degradosome, SUV3 and PNPase, is upregulated in AML cells and stem cells and functionally important for degradation of mtRNA and mitochondrial dsRNA (double stranded RNA) in AML. Depleting SUV3 or PNPase impairs mtRNA degradation and promotes the accumulation of dsRNA. dsRNA that accumulates after depleting SUV3 or PNPase, stimulates IFN-I signaling that induces AML differentiation, decreases stemness and increases sensitivity to immune-mediating cytotoxicity. Thus, this work highlights mitochondrial RNA regulation in AML and identifies a mechanism by which mtRNA turnover influences AML differentiation, stem cell function, and immune sensitization.
Insights
Mitochondrial RNA (mtRNA) turnover is elevated in Acute Myeloid Leukemia (AML). Upregulation of SUV3 and PNPase in AML cells degrades mtRNA, and their depletion increases double-stranded RNA (dsRNA), promoting AML differentiation and immune sensitization.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Eukaryotic cells possess distinct nuclear and mitochondrial genomes.
- Mitochondrial DNA (mtDNA) transcription generates mitochondrial RNA (mtRNA) and double-stranded RNA (dsRNA) as byproducts.
- Altered RNA metabolism is implicated in various cancers, including Acute Myeloid Leukemia (AML).
Purpose of the Study:
- To investigate the role of mitochondrial RNA regulation in AML.
- To identify key factors involved in mtRNA turnover in AML cells and stem cells.
- To explore the functional consequences of mtRNA dysregulation on AML biology and immune response.
Main Methods:
- Quantification of mtRNA transcription and degradation rates in AML cells and stem cells.
- Analysis of mitochondrial degradosome component (SUV3, PNPase) expression in AML.
- Functional studies involving depletion of SUV3 or PNPase to assess mtRNA and dsRNA levels.
- Evaluation of IFN-I signaling, AML differentiation, stemness, and immune sensitization following dsRNA accumulation.
Main Results:
- Increased mtRNA transcription and degradation rates observed in AML cells and stem cells, leading to higher mtRNA turnover.
- The mitochondrial degradosome components, SUV3 and PNPase, are upregulated in AML cells and stem cells.
- Depletion of SUV3 or PNPase impairs mtRNA degradation, causing dsRNA accumulation.
- Accumulated dsRNA stimulates IFN-I signaling, inducing AML differentiation, reducing stemness, and enhancing immune-mediated cytotoxicity.
Conclusions:
- Mitochondrial RNA regulation plays a significant role in AML pathogenesis.
- The mitochondrial degradosome (SUV3, PNPase) is crucial for mtRNA and dsRNA degradation in AML.
- mtRNA turnover influences AML cell differentiation, stem cell properties, and susceptibility to immune attack, offering potential therapeutic targets.
More Related Videos
Related Concept Videos
RNA Stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Nuclear Export of mRNA
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
MicroRNAs

